BC Centre for Excellence in HIV/AIDS
Home
News & Multimedia
Events
About Us
Join Us
Contact
On Facebook
On Twitter
Treatment as Prevention
Treatment as Prevention
STOP HIV/AIDS
TasP International Workshop
Research
Epidemiology & Population Health
Gender & Sexual Health Initiative
Incentives
International Program
Laboratory Program
Urban Health Research Initiative
Clinical Activities
AIDS Research Program
Addiction Medicine Fellowship
Clinical Programs
Education & Training
Lab Tests
Publications
Articles & Papers
BC-CfE Documents
Forecast Newsletter
Search this site:
Harris M's Publications
A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population
2009
|
Nephron Clinical Practice
|
Barraclough K
A Randomized, Open-label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor Sparing Regimen in Antiretroviral-Naïve, HIV-Infected Patients
2009
|
JAIDS Journal of Acquired Immune Deficiency Syndromes
|
Harris M
Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults
2009
|
Canadian Journal of Infectious Diseases and Medical Microbiology
|
Harris M
Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation
2009
|
Journal of Clinical Pharmacology
|
Hull M
Managing the nephrotoxic effects of HAART
2009
|
Nature Reviews Nephrology
|
Izzedine H
Optimal use of raltegravir in the treatment of HIV-infected adults – Canadian consensus guidelines
2009
|
Canadian Journal of Infectious Diseases and Medical Microbiology
|
Rachlis AR
Raltegravir: its use in the treatment of HIV infection
2009
|
Clinical Medicine: Therapeutics
|
Harris M
Exacerbation of depression associated with starting raltegravir: a report of four cases
2008
|
AIDS
|
Harris M
Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients
2008
|
Expert Opinion on Drug Safety
|
Harris M
Outcomes of multidrug-resistant patients switched from enfuvirtide to raltegravir within a virologically suppressive regimen
2008
|
AIDS
|
Harris M
1
2
3
4
5
next ›
last »
For Healthcare Providers
Therapeutic Guidelines
Up-to-date HIV treatment info
Drug Treatment Program
Information on anti-HIV medications
HIV Drug Safety
Report reactions and side-effects
Healthcare Resources
Resources of particular interest to Healthcare Professionals
Sign up for the BC-CfE Newsletter:
*